Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.51 USD
−20.84 M USD
0.00 USD
6.92 M
About Lisata Therapeutics, Inc.
Sector
CEO
David J. Mazzo
Headquarters
Basking Ridge
Website
Founded
1980
FIGI
BBG000BNVDR4
Lisata Therapeutics, Inc. is engaged in the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. It also actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs more efficiently penetrating and accumulating in the tumor, while normal tissues are unlikely to be affected. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LSTA is 3.13 USD — it has increased by 1.71% in the past 24 hours. Watch Lisata Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lisata Therapeutics, Inc. stocks are traded under the ticker LSTA.
LSTA stock has risen by 23.94% compared to the previous week, the month change is a 6.71% rise, over the last year Lisata Therapeutics, Inc. has showed a 10.21% increase.
We've gathered analysts' opinions on Lisata Therapeutics, Inc. future price: according to them, LSTA price has a max estimate of 15.00 USD and a min estimate of 13.00 USD. Watch LSTA chart and read a more detailed Lisata Therapeutics, Inc. stock forecast: see what analysts think of Lisata Therapeutics, Inc. and suggest that you do with its stocks.
LSTA reached its all-time high on Jan 24, 2000 with the price of 637,500.00 USD, and its all-time low was 1.95 USD and was reached on Sep 15, 2023. View more price dynamics on LSTA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LSTA stock is 4.49% volatile and has beta coefficient of −0.38. Track Lisata Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Lisata Therapeutics, Inc. there?
Today Lisata Therapeutics, Inc. has the market capitalization of 25.98 M, it has increased by 19.96% over the last week.
Yes, you can track Lisata Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Lisata Therapeutics, Inc. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
LSTA earnings for the last quarter are −0.59 USD per share, whereas the estimation was −0.75 USD resulting in a 21.33% surprise. The estimated earnings for the next quarter are −0.76 USD per share. See more details about Lisata Therapeutics, Inc. earnings.
Lisata Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
LSTA net income for the last quarter is −4.93 M USD, while the quarter before that showed −5.04 M USD of net income which accounts for 2.26% change. Track more Lisata Therapeutics, Inc. financial stats to get the full picture.
No, LSTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 25.00 employees. See our rating of the largest employees — is Lisata Therapeutics, Inc. on this list?
Like other stocks, LSTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lisata Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lisata Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lisata Therapeutics, Inc. stock shows the sell signal. See more of Lisata Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.